EUVIMEDEUVIMED entdecken
Crossref

Abstract 1270: Informed Consent for Endovascular Thrombectomy: A Survey on Provider Practices and Perspectives

M. J. Young, P. P. Krieger, A. A. Mbonde, A. A. Dmytriw, J. A. Hirsch, A. B. Singhal, S. A. Sheth, T. M. Leslie-Mazwi, A. B. Patel, N. S. Rost, R. W. Regenhardt

Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)

DOI: 10.1161/svi270000_1270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von M. J. Young und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Informed Consent for Endovascular Thrombectomy: A Survey on Provider Practices and Perspectives Young MJ*, Krieger PP*, Mbonde AA, Dmytriw AA, Hirsch JA, Singhal AB, Sheth SA, Leslie-Mazwi TM, Patel AB, Rost NS, Regenhardt RW SVIN requirements: Title 12/15 wordsCharacter Count 398/400 wordsGraphics 1/1 Introduction: While endovascular thrombectomy (EVT) is an highly effective therapy, approaches to informed consent (IC) vary considerably, particularly when patients lack capacity or surrogates. We sought to characterize providers’ approaches to IC, circumstances considered to justify waiving IC, and the perceived importance of IC.

Methods

From July to December 2023, a cross-sectional online survey was distributed to providers involved in acute stroke. It was created using Qualtrics and distributed through institutional networks, professional societies, StrokeNet, and social media. Respondents reported their approaches to IC, assessment of capacity, management of patients lacking capacity/surrogates, perceived importance of IC, attitudes toward IC waivers, and the importance of guidelines.

Results

A total of 283 respondents answered questions required for this analysis. 82% were staff physicians, 79% in USA, and 75% at academic centers. Most respondents reported waiving IC some of the time (75%), with 8% always and 17% never waiving. During IC discussions, 75% reported providing qualitative risk-benefit information, 68% detailed procedural information, 55% quantitative risk-benefit information, and 50% their own opinion regarding optimal treatment; only 12% reported using written/visual decision aids. 80% reported checking patient/surrogate understanding before IC. Capacity was most commonly assessed by ability to answer questions (81%), communicate fluently (60%), and demonstrate orientation (58%); 12% used a formal evaluation tool. When an EVT-eligible patient lacked capacity/surrogate, 97% reported they would proceed with EVT. Respondents indicated that patients/surrogates declined EVT in a median of 5% cases that the clinical team felt reasonable to treat. The most frequently reported reasons for declining were goals of care (63%), life expectancy (58%), advanced age (47%), and procedural aversion (28%). 77% of respondents considered obtaining IC at least moderately important, although this was lower among neurointerventionalists (71% vs 82%, p=0.044). 55% considered IC for EVT equally important as IC for intravenous thrombolysis, whereas 31% considered it more important. Waiver of IC was considered justifiable when a surrogate was unavailable (81%), given time-sensitive nature (67%), when the patient lacked capacity (66%), or when potential benefit was clear (55%). 70% considered harmonized IC guidelines at least moderately useful, although this was lower among neurosurgeons (51% vs 72%, p=0.021).

Conclusions

Providers regard IC for EVT as important, yet employ heterogeneous approaches and endorse substantial flexibility. These findings suggest a role for formal guidelines that preserves patient/surrogate involvement without introducing delays. Developing unified standards for IC may help reconcile competing imperatives, mitigate medicolegal exposure, and require multidisciplinary collaboration.

Zitieren

APA

Young, M. J., Krieger, P. P., Mbonde, A. A., Dmytriw, A. A., Hirsch, J. A., Singhal, A. B., Sheth, S. A., Leslie-Mazwi, T. M., Patel, A. B., Rost, N. S., & Regenhardt, R. W. (2026). Abstract 1270: Informed Consent for Endovascular Thrombectomy: A Survey on Provider Practices and Perspectives. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1270

Vancouver

Young MJ, Krieger PP, Mbonde AA, Dmytriw AA, Hirsch JA, Singhal AB, et al. Abstract 1270: Informed Consent for Endovascular Thrombectomy: A Survey on Provider Practices and Perspectives. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1270

BibTeX
@article{Young2026,
  author = {Young, M. J. and Krieger, P. P. and Mbonde, A. A. and Dmytriw, A. A. and Hirsch, J. A. and Singhal, A. B. and Sheth, S. A. and Leslie-Mazwi, T. M. and Patel, A. B. and Rost, N. S. and Regenhardt, R. W.},
  title = {Abstract 1270: Informed Consent for Endovascular Thrombectomy: A Survey on Provider Practices and Perspectives},
  journal = {Stroke: Vascular and Interventional Neurology},
  year = {2026},
  volume = {6},
  number = {Suppl_1},
  doi = {10.1161/svi270000_1270}
}
Kostenlos starten →